Observation of high and low molecular weight inhibitors of angiotensin-converting enzyme in rat lung

Archives Internationales de Pharmacodynamie et de Therapie

Volumn 331, Issue 3, 1996, Pages 301-312

  Brecher, A S ^a   Thevananther, S ^a   Wilson, S ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; LUNG; NONHUMAN; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CHROMATOGRAPHY, AFFINITY; LUNG; MOLECULAR WEIGHT; PEPTIDYL-DIPEPTIDASE A; RATS;

EID: 0030444786     PISSN: 00039780     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ARIYOSHI, Y. Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci. Techn. 4, 139-144 (1993).
2. BULL, H. G., THORNBERRY, N. A. and CORDES, E. H. Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. J. biol. Chem. 260, 2963-2972 (1985).
3. DEFELICE, S. L. The nutraceutical revolution: Its impact on food industry R & D. Trends Food Sci. Techn. 6, 59-61 (1995).
4. GAVRAS, H. and GAVRAS, I. Angiotensin converting enzyme inhibitors. Properties and side effects. Hypertension 11, Suppl. II, 37-41 (1988).
5. GAVRAS, H., BRUNNER, H. R., LARAGH, J. H., SEALEY, J. E., GAVRAS, I. and VUKOVICH, R. A. Angiotensin converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. New Engl. J. Med. 291, 817-821 (1974).
6. GAVRAS, H., FLESSAS, A., RYAN, T. J., BRUNNER, H. R., FAXON, D. P. and GAVRAS, J. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension. J. amer. med. Ass. 238, 880-882 (1977).
7. GOLD, E. H., NEUSTADT, B. R. and SMITH, E. M. U.S. Patent 4,470,972 (1984).
8. HARRIS, E. E., PATCHETT, A. A., TRISTAN, E. W. and WYVRATT, M. J. U.S. Patent 4,374,829 (1983).
9. HOOPER, N. M. Angiotensin converting enzyme: Its implications from molecular biology for its physiological functions. Int. J. Biochem. 23, 641-647 (1991).
10. HURST, P. J. and SMITH, C. J. L. Optimized assay for serum angiotensin-converting enzyme activity. Clin. Chem. 27, 2048-2052 (1981).
11. IKEMOTO, F., SONG, G. B., TOMINAGA, M. and YAMAMOTO, K. Endogenous inhibitor of angiotensin converting enzyme identified from the rat heart. In: McGregor, G. A. and Sever, P. S. (Eds.). Current Advances in ACE Inhibition, pp. 179-181. Churchill Livingstone, Edinburgh (1989).
12. KLAUSNER, R. J., ROBINSON, C. J. G. and ERDÖS, E. G. Inhibition of kininase II (angiotensin I converting enzyme) by human serum albumin and its fragments. Adv. exp. Med. Biol. 120B, 477-485 (1979).
13. KOHAMA, Y., OKA, H., YAMAMOTO, K., TERAMOTO, T., OKABE, M., MIMURA, T., NAGASE, Y., CHIBA, Y. and FUJITA, T. Induction of angiotensin-converting enzyme inhibitory activity by acid-limited proteolysis of glyceraldehyde 3-phosphate dehydrogenase. Biochem. biophys. Res. Commun. 161, 456-460 (1989).
14. LANZILLO, J. J. and FANBURG, B. L. Membrane-bound angiotensin-converting enzyme from rat lung. J. biol. Chem. 249, 2312-2318 (1974).
15. LANZILLO, J. J., STEVENS, J., DASARATHY, Y., YOTSUMOTO, H. and FANBURG, B. L. Angiotensin-converting enzyme from human tissues. Physicochemical, catalytic and immunological properties. J. biol. Chem. 260, 14938-14944 (1985).
16. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J. Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265-275 (1951).
17. MARUYAMA, S., NAKAGOMI, K., TOMIZUKA, N. and SUZUKI, H. Angiotensin I converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation of bradykinin-potentiating activity on the uterus and the ileum of rats. Agric. biol. Chem. 49, 1405-1409 (1985).
18. MEISEL, H. Casokinins as bioactive peptides in the primary structure of casein. In: Schwenke, K. D. and Mothes, R. (Eds.). Food Proteins - Structure Functionality, pp. 67-75. VCH, Weinheim, New York (1993).
19. MEISEL, H. and SCHLIMME, E. Inhibitors of angiotensin converting enzyme derived from bovine casein (casokinins). In: Brantl, V. and Teschemacher, H. (Eds.). β-Casomorphins and Related Peptides - Recent Developments, pp. 27-33. VCH, Weinheim, New York (1994).
20. MULLALY, M. M., MEISEL, H. and FITZGERALD, R. J. Synthetic peptides corresponding to α-lactalbumin and β-lactalbumin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. Hoppe-Seyler 377, 259-260 (1996).
21. NISHIMURA, K., HIWADA, K., UEDA, E. and KOKUBU, T. Affinity chromatography of angiotensin I-converting enzyme from rabbit lung using hippuryl histidyl leucyl-OH. Biochim. biophys. Acta 445, 158-160 (1976).
22. ONDETTI, M. A. and KRAPCHO, J. U.S. Patent 4,316,906 (1982).
23. RYAN, J. W. Angiotensin converting enzyme, dipeptidyl carboxypeptidase I, and its inhibitors. Meth. Enzymol. 163, 192-210 (1988).
24. RYAN, J. W., MARTIN, J. C., CHAUNG, A. and PENA, G. A. Mammalian inhibitors of angiotensin converting enzyme (kininase II). In: Fuji, S., Moriya, H. and Suzuki, T. (Eds.). Advances in Experimental Medicine and Biology. Kinins II, Vol. 120B, pp. 599-606. Plenum, New York (1979).
25. SANTOS, R. A. S., KRIEGER, E. M. and GREENE, L. J. An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension 7, 244-252 (1985).
26. SCHARPÉ, S., DE MEESTER, I., HENDRIKS, D., VANHOOF, G., VAN SANDE, M. and VRIEND, G. Proteases and their inhibitors: Today and tomorrow. Biochimie 73, 121-126 (1991).
27. SEKIYA, S., KOBAYASHI, Y., KITA, E., IMAMURA, Y. and TOYAMA, S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J. jap. Soc. Nutr. Food Sci. 45, 513-517 (1992).
28. SPINOSA, G., PERLANSKI, E., LEENEN, F. H. H., STEWART, R. B. and GRUPP, L. A. Angiotensin converting enzyme inhibitors: Animal experiments suggest a new pharmacological treatment for alcohol abuse in humans. Alcoholism: Clin. exp. Res. 12, 65-70 (1988).
29. SUNDBERG, L. and PORATH, J. Preparation of adsorbents for biospecific affinity chromatography. I. Attachment of group-containing ligands to insoluble polymers by means of bifunctional oxiranes. J. Chromatogr. 90, 87-98 (1974).
30. TAIRA, H., MIZUTANI, S., KARAUCHI, O., NARITA, O. and TOMODA, Y. Rapid purification of human placental angiotensin I converting enzyme by captopril affinity chromatography. J. Chromatogr. 339, 399-403 (1985a).
31. TAIRA, H., MIZUTANI, S., NARITA, O. and TOMODA, Y. Angiotensin I-converting enzyme in human placenta. Placenta 6, 543-549 (1985b).
32. USINGER, P., HOCK, F. J., WIEMER, G., GERHARDS, H. J., HENNING, R. and URBACH, H. Indications on the memory-enhancing effects of a peptidase inhibitor. Drug Developm. Res. 14, 315-324 (1988).
33. YANG, H. Y. T., ERDÖS, E. G. and LEWIN, Y. Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). J. Pharmacol. exp. Ther. 177, 291-300 (1971).